{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:40:30Z","timestamp":1790635230556,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pdpdt.2021.102582","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T07:26:49Z","timestamp":1634023609000},"page":"102582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Long-term effect of intravitreal aflibercept treatment on choroidal vascularity index in neovascular age-related macular degeneration"],"prefix":"10.1016","volume":"36","author":[{"given":"Abdulkadir","family":"Alis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Guler Alis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pdpdt.2021.102582_bib0001","first-page":"3936","article-title":"Age-related retinal pigment epithelium and Bruch's membrane degeneration in senescence-accelerated mouse","volume":"41","author":"Majji","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.pdpdt.2021.102582_bib0002","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/07853890600946724","article-title":"Age-related macular degeneration\u2013emerging pathogenetic and therapeutic concepts","volume":"38","author":"Gehrs","year":"2006","journal-title":"Ann. Med."},{"key":"10.1016\/j.pdpdt.2021.102582_bib0003","series-title":"Hastal\u0131klar\u0131","first-page":"677","author":"O'Dwyer","year":"2015"},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102582_bib0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1258\/jrsm.2009.080298","article-title":"Age-related macular degeneration","volume":"102","author":"Ayoub","year":"2009","journal-title":"J. R. Soc. Med."},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102582_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9394(99)00207-X","article-title":"Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study","volume":"128","author":"Lewis","year":"1999","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102582_bib0006","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/112067210601600119","article-title":"Hypericin-enhanced argon laser photocoagulation for subfoveal choroidal neovascular membrane in age-related macular degeneration: a pilot study","volume":"16","author":"Sobaci","year":"2006","journal-title":"Eur. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.pdpdt.2021.102582_bib0007","first-page":"1049","article-title":"Photodynamic therapy versus thermal laser photocoagulation for the treatment of recurrent choroidal neovascularization due to AMD","volume":"21","author":"Kallitsis","year":"2007","journal-title":"In Vivo (Brooklyn)"},{"issue":"6","key":"10.1016\/j.pdpdt.2021.102582_bib0008","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1055\/s-0028-1110015","article-title":"Photodynamische Therapie mit Verteporfin bei okkulter chorioidaler Neovaskularisation im Rahmen der altersbezogenen Makuladegeneration [Photodynamic therapy with verteporfin in occult choroidal neovascularization in age-related macular degeneration]","volume":"227","author":"K\u00fcrzinger","year":"2010","journal-title":"Klin. Monbl. Augenheilkd"},{"issue":"5","key":"10.1016\/j.pdpdt.2021.102582_bib0009","first-page":"855","article-title":"Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes","volume":"37","author":"Lopez","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.pdpdt.2021.102582_bib0010","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.clinthera.2007.09.008","article-title":"Ranibizumab for the treatment of neovascular age-related macular degeneration: a review","volume":"29","author":"Kourlas","year":"2007","journal-title":"Clin. Ther."},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102582_bib0011","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"8","author":"Solomon","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.pdpdt.2021.102582_bib0012","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"27","key":"10.1016\/j.pdpdt.2021.102582_bib0013","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102582_bib0014","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.pdpdt.2021.102582_bib0015","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00417-015-3260-3","article-title":"Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration","volume":"254","author":"Yun","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"3","key":"10.1016\/j.pdpdt.2021.102582_bib0016","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/02713683.2017.1405045","article-title":"Comparison of short-term choroidal thickness and retinal morphological changes after intravitreal Anti-VEGF therapy with ranibizumab or aflibercept in treatment-naive eyes","volume":"43","author":"Gharbiya","year":"2018","journal-title":"Curr. Eye Res."},{"issue":"6","key":"10.1016\/j.pdpdt.2021.102582_bib0017","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/jop.2014.0160","article-title":"Choroidal thickness changes after intravitreal antivascular endothelial growth factor therapy for age-related macular degeneration: ranibizumab versus aflibercept","volume":"31","author":"Gharbiya","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.pdpdt.2021.102582_bib0018","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1167\/iovs.14-14447","article-title":"Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images","volume":"55","author":"Sonoda","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102582_bib0019","doi-asserted-by":"crossref","first-page":"e770","DOI":"10.1111\/aos.13442","article-title":"Influence of scanning area on choroidal vascularity index measurement using optical coherence tomography","volume":"95","author":"Agrawal","year":"2017","journal-title":"Acta Ophthalmol."},{"issue":"7","key":"10.1016\/j.pdpdt.2021.102582_bib0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102582_bib0021","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00417-020-04740-6","article-title":"A comparative study of the choroidal vascularity indexes in the fellow eyes of patients with pachychoroid neovasculopathy and central serous chorioretinopathy by binarization method","volume":"258","author":"Demirel","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102582_bib0022","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12886-018-0749-7","article-title":"Short-term changes of choroidal vascular structures after phacoemulsification surgery","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Ophthalmol."},{"issue":"10","key":"10.1016\/j.pdpdt.2021.102582_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164672","article-title":"Choroidal structure in children with anisohypermetropic amblyopia determined by binarization of optical coherence tomographic images","volume":"11","author":"Nishi","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102582_bib0024","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.1038\/s41598-017-08276-4","article-title":"Choroidal remodeling in age-related macular degeneration and polypoidal choroidal vasculopathy: a 12-month prospective study","volume":"7","author":"Ting","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.pdpdt.2021.102582_bib0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00417-020-04957-5","article-title":"Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration","volume":"259","author":"Pellegrini","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.pdpdt.2021.102582_bib0026","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jfo.2017.04.014","article-title":"Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: ranibizumab versus aflibercept","volume":"40","author":"Kaya","year":"2017","journal-title":"J. Fr. Ophtalmol."},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102582_bib0027","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12886-020-01542-6","article-title":"Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration","volume":"20","author":"Itagaki","year":"2020","journal-title":"BMC Ophthalmol."},{"issue":"3","key":"10.1016\/j.pdpdt.2021.102582_bib0028","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ophtha.2015.10.039","article-title":"Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration: twelve-month results","volume":"123","author":"Koizumi","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.pdpdt.2021.102582_bib0029","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40259-016-0179-0","article-title":"Choroidal thickness changes after intravitreal ranibizumab for exudative age-related macular degeneration","volume":"30","author":"Minnella","year":"2016","journal-title":"BioDrugs"},{"issue":"7","key":"10.1016\/j.pdpdt.2021.102582_bib0030","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1111\/aos.13399","article-title":"Choroidal vascular changes in age-related macular degeneration","volume":"95","author":"Koh","year":"2017","journal-title":"Acta Ophthalmol."},{"issue":"6","key":"10.1016\/j.pdpdt.2021.102582_bib0031","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/IAE.0000000000001312","article-title":"Choroidal vascularity index: a novel optical coherence tomography based parameter in patients with exudative age-related macular degeneration","volume":"37","author":"Wei","year":"2017","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.pdpdt.2021.102582_bib0032","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00417-017-3591-3","article-title":"Choroidal structures in polypoidal choroidal vasculopathy, neovascular age-related maculopathy, and healthy eyes determined by binarization of swept source optical coherence tomographic images","volume":"255","author":"Bakthavatsalam","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"5","key":"10.1016\/j.pdpdt.2021.102582_bib0033","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s10384-018-0615-4","article-title":"Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"62","author":"Takahashi","year":"2018","journal-title":"Jpn. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.pdpdt.2021.102582_bib0034","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1111\/aos.13763","article-title":"Choroidal blood flow after the first intravitreal ranibizumab injection in neovascular age-related macular degeneration patients","volume":"96","author":"Mottet","year":"2018","journal-title":"Acta Ophthalmol."},{"issue":"5","key":"10.1016\/j.pdpdt.2021.102582_bib0035","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00417-018-3939-3","article-title":"Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema","volume":"256","author":"Okamoto","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021004038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021004038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:47:21Z","timestamp":1761612441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100021004038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"alternative-id":["S1572100021004038"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102582","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effect of intravitreal aflibercept treatment on choroidal vascularity index in neovascular age-related macular degeneration","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102582"}}